Ghazal Shariat Panahi - Nano Fanavaran Narin Teb Co., Tehran, Iran
Mohammad Darvishi - Infectious Diseases and Tropical Medicine Research Center (IDTMRC), Aerospace and subaquatic Medicine Faculty, AJAUMS, Tehran, Iran
Mehdi Akbarzadeh - Sadra Wound, Ostomy and Osteomyelitis Specialist Center, , Tehran, Iran
Maryam Barkhordari - Wound clinic of Imam Hussein Hospital Medical Center, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran
Amir Ghasemi - Nano Fanavaran Narin Teb Co., Tehran, Iran

Objective: This clinical study aimed to evaluate the performance and safety of NanoEx wound dressing (Nano Fanavaran Narin teb Co., Iran) in the management of acute and chronic wounds. Methods: Forty patients suffering from wounds with different etiologies were enrolled. The wounds were evaluated for healing rate, wound area, wound bed tissue, exudate, and pain levels. Weekly assessments were done using wound evaluation forms and via digital photography. Results: After ۲۱.۲۵ days, wound area decreased by ۷۰.۶%, respectively, with a healing rate of ۵.۴۶ %/day. After ۹ weeks, ۵۷.۵% of wounds completely healed with a healing rate of ۵.۷ %/day. Wound-related pain and exudate met a significant (p < .۰۰۱) decrease, reducing by two and four points, respectively. The percentage of epithelialized tissue increased by ۵۷.۲%. Also, the percentage of slough and necrotic tissue decreased by more than ۹۰%, showing a significant decrease (p < ۰.۰۵). Conclusions: In general, NanoEx wound dressing was safe and efficient for the treatment of acute and chronic wounds

burn, exudate, infection, pain, wound dimension, wound healing